Alfuzosin for benign prostatic hypertrophy.
Chapple
C R
CR
D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D006801:Humans; D008297:Male; D011224:Prazosin / Q000008:administration & dosage; D011470:Prostatic Hyperplasia / Q000188:drug therapy*; D011799:Quinazolines / Q000627:therapeutic use*; D014563:Urodynamics
D000317:Adrenergic alpha-Antagonists; D011799:Quinazolines; C047638:alfuzosin; D011224:Prazosin